Grant: Engage Grants Program
Dalhousie University
$25,000.00
Studies of iron uptake and regulation in animal cells and affects of novel iron chelators
EF 2012-13
Résumé
Iron is needed for the growth of all animal cells, being necessary for the proper function of many different
enzyme systems and the expression of certain important genes, as well as for the production of oxygen radicals
that help defend against microorganisms. Given the key roles for iron in cell growth, metabolism, and host
defence, a better understanding of iron uptake and its regulation by different animal cell types could provide
important new information as to the functioning of animal cells under normal and disease conditions. However,
studies of iron requirements and the effects of iron withdrawal on animal cells have been limited by the lack of
suitable model cell systems in which iron supply can be fully controlled and the lack of iron-withdrawing
agents that are more selective in their action. Chelation Partners Incorporated (CPI) has developed a new
family of highly selective iron-withdrawing agents (iron chelators), and is interested to determine whether these
agents are active with animal cells. In this collaborative research project the Hoskin laboratory will use novel
iron-withdrawing agents from CPI to compare specific iron requirements and iron uptake in mouse versus
human cells of differing types. Counterpart malignant cell lines will be used to test the hypothesis that cells that
grow continuously may have higher and/or more continuous iron requirements. The effect of iron withdrawal
on the activity of other cell growth inhibitors will also be determined. The proposed research will yield new
insights into iron regulation and dysregulation in animal cells, leading to the identification of potential new
pathways for controlling cell growth at the level of iron requirements. This new information will have
important biotechnology and biomedical applications for Canada.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
429769-2012
Name nom
Hoskin, David
Department département
Microbiology and Immunology
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
1
Application title
Studies of iron uptake and regulation in animal cells and affects of novel iron chelators
Keyword
NSERC
Application summary
Iron is needed for the growth of all animal cells, being necessary for the proper function of many different
enzyme systems and the expression of certain important genes, as well as for the production of oxygen radicals
that help defend against microorganisms. Given the key roles for iron in cell growth, metabolism, and host
defence, a better understanding of iron uptake and its regulation by different animal cell types could provide
important new information as to the functioning of animal cells under normal and disease conditions. However,
studies of iron requirements and the effects of iron withdrawal on animal cells have been limited by the lack of
suitable model cell systems in which iron supply can be fully controlled and the lack of iron-withdrawing
agents that are more selective in their action. Chelation Partners Incorporated (CPI) has developed a new
family of highly selective iron-withdrawing agents (iron chelators), and is interested to determine whether these
agents are active with animal cells. In this collaborative research project the Hoskin laboratory will use novel
iron-withdrawing agents from CPI to compare specific iron requirements and iron uptake in mouse versus
human cells of differing types. Counterpart malignant cell lines will be used to test the hypothesis that cells that
grow continuously may have higher and/or more continuous iron requirements. The effect of iron withdrawal
on the activity of other cell growth inhibitors will also be determined. The proposed research will yield new
insights into iron regulation and dysregulation in animal cells, leading to the identification of potential new
pathways for controlling cell growth at the level of iron requirements. This new information will have
important biotechnology and biomedical applications for Canada.